VKTX — Viking Therapeutics, Inc. stock price, charts and financials

QT47Viking Therapeutics, Inc.

Viking Therapeutics, Inc. (NASDAQ: VKTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
32.94
+0.33+1.01%
OverviewShort InterestFilings
VKTXQT47Viking Therapeutics, Inc.·NASDAQ
32.94+1.01%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 2026S-3ASRS-3ASR
Jul 29, 20268-KCurrent report
Jul 29, 20264Statement of changes in beneficial ownership
Jul 29, 20264Statement of changes in beneficial ownership
Jul 29, 20264Statement of changes in beneficial ownership
Jul 29, 202610-QQuarterly report
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20263Initial statement of beneficial ownership
May 26, 20268-KCurrent report
Apr 30, 202610-QQuarterly report
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 20268-KCurrent report
Apr 01, 2026DEF 14ADefinitive proxy statement
Apr 01, 2026ARSAnnual report to shareholders
Apr 01, 2026DEFA14AAdditional proxy soliciting materials
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 10, 20264Statement of changes in beneficial ownership
Feb 11, 20268-KCurrent report
Feb 11, 202610-KAnnual report
Jan 26, 20264Statement of changes in beneficial ownership
Jan 26, 20263Initial statement of beneficial ownership
Jan 05, 20264Statement of changes in beneficial ownership
Jan 05, 20264Statement of changes in beneficial ownership
Jan 05, 20264Statement of changes in beneficial ownership
Jan 05, 20264Statement of changes in beneficial ownership
#1 / 25 of 241
Page
▼
/ 10